Intrathecal Dexmedetomidine 5 mcg Versus 10 mcg With Bupivacaine for Infra-umbilical Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 544 participants.

Also called NCT07929818

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 544 participants (enrolled count) (from the registry)
Sponsor
Hussain Aziz Bhatti (from the registry)
Registry
  • NCT NCT07929818
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07929818. Randomized; single masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2026-10-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intrathecal Dexmedetomidine 5 mcg Versus 10 mcg With Bupivacaine for Infra-umbilical Surgery
Condition
Spinal Anesthesia
Condition
Intraoperative Hypotension
Condition
Bradycardia
Intervention (Drug)
Dexmedetomidine 5 micrograms (intrathecal)
Intervention (Drug)
Dexmedetomidine 10 micrograms (intrathecal)
Intervention (Drug)
Hyperbaric bupivacaine 0.5%
Lead sponsor
Hussain Aziz Bhatti (class: other government)

Record details

Record id
cardio:ct-nct07929818
Content hash
7ec39522bcd9b018b7ccc9bcd40bf83165052ef3f9e43808d6c6683658604134